NCT04504955View on ClinicalTrials.gov

CorEvitas Atopic Dermatitis Registry: a Study of Post Approval Drug Safety and Effectiveness

Enrolling by invitationOBSERVATIONAL

Enrollment

10,000

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

December 31, 2100

Study Completion Date

December 31, 2100

Conditions

Atopic Dermatitis

Interventions

OTHER

Observational Non-Interventional Registry

Observational Non-Interventional Registry

Trial Locations (1)

02451

CorEvitas, LLC, Waltham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

CorEvitas

NETWORK